Literature DB >> 2554803

Antagonism of the cytotoxic but not antiviral effects of ara-sangivamycin by adenosine.

G M Birch1, S H Krawczyk, L B Townsend, J C Drach.   

Abstract

Inhibition of DNA synthesis by ara-sangivamycin was antagonized by adenosine. The 50% inhibitory concentrations increased 1.6- to 32-fold in the presence of 1.0 to 50 microM adenosine, respectively. In contrast, the inhibition of human cytomegalovirus replication by ara-sangivamycin was not antagonized by as much as 50 microM adenosine. This suggests that different enzymes were responsible for the phosphorylation of ara-sangivamycin in uninfected and infected cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554803      PMCID: PMC172710          DOI: 10.1128/AAC.33.9.1606

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Adenosine kinase from rabbit liver. II. Substrate and inhibitor specificity.

Authors:  R L Miller; D L Adamczyk; W H Miller; G W Koszalka; J L Rideout; L M Beacham; E Y Chao; J J Haggerty; T A Krenitsky; G B Elion
Journal:  J Biol Chem       Date:  1979-04-10       Impact factor: 5.157

2.  Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.

Authors:  S H Smith; C Shipman; J C Drach
Journal:  Cancer Res       Date:  1978-07       Impact factor: 12.701

3.  Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity.

Authors:  T A Krenitsky; J V Tuttle; G W Koszalka; I S Chen; L M Beacham; J L Rideout; G B Elion
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

4.  Specificity of adenosine deaminase inhibitors.

Authors:  J F Henderson; L Brox; G Zombor; D Hunting; C A Lomax
Journal:  Biochem Pharmacol       Date:  1977-11-01       Impact factor: 5.858

Review 5.  Antiviral chemotherapy for cytomegalovirus disease.

Authors:  D J Morris
Journal:  J Antimicrob Chemother       Date:  1988-05       Impact factor: 5.790

6.  Pyrrolopyrimidine lethality in relation to ribonucleic acid synthesis in sarcoma 180 cells in vitro.

Authors:  P S Ritch; M Helmsworth
Journal:  Biochem Pharmacol       Date:  1982-08-15       Impact factor: 5.858

7.  Kinetic effects of sangivamycin in sarcoma 180 in vitro.

Authors:  P S Ritch; R I Glazer; R E Cunningham; S E Shackney
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

8.  Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro.

Authors:  E C Mar; P C Patel; Y C Cheng; J J Fox; K A Watanabe; E S Huang
Journal:  J Gen Virol       Date:  1984-01       Impact factor: 3.891

9.  Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents.

Authors:  J M Colacino; C Lopez
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.

Authors:  A K Field; M E Davies; C DeWitt; H C Perry; R Liou; J Germershausen; J D Karkas; W T Ashton; D B Johnston; R L Tolman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

View more
  1 in total

1.  Nonnucleoside pyrrolopyrimidines with a unique mechanism of action against human cytomegalovirus.

Authors:  J G Jacobson; T E Renau; M R Nassiri; D G Sweier; J M Breitenbach; L B Townsend; J C Drach
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.